fbpx

Hyperlipidemia Remains Resolved 12 years Later After Metabolic Surgery

Posted on: 15th Nov, 2020

Before and After Image of Patient from Sasse Surgical

One of the more striking findings we see every week in our long-term follow-up clinic for patients with obesity, type 2 diabetes, and past metabolic surgery is the profound drop in triglycerides after metabolic surgery.

While elevated LDL cholesterol commonly falls over the years following metabolic surgery, the abrupt drop in triglycerides is swift and more profound. Both sleeve gastrectomy and Roux en Y gastric bypass create changes in the hormonal biochemistry of the body that result in improved lipid profile and metabolic function. While several bioactive peptides are implicated, the precise mechanism of the lipid improvements remains undetermined. Hormones GLP-1 and PYY are increased after sleeve and gastric bypass, and hormones ghrelin and leptin are reduced, perhaps offering a trail for researchers to follow, to explain lipid effects through a gut-intestine-liver-brain mechanism. We know that triglycerides fall especially reliably in animal models of sleeve and bypass, independent of weight effects, just as occurs in humans.

These findings are illustrated in a New England Journal of Medicine study that examined 1,156 patients including control groups of patients who did not undergo metabolic surgery. 12 years later, all metabolic parameters favored the metabolic surgery group, and most striking is the near complete resolution of hypertriglyceridemia.

 

Interestingly, the profound reduction in triglycerides likely adds to the factors of CV risk reduction from bariatric surgery, namely lowering LDL-C, blood pressure and Hgba1c in reducing cardiovascular risks.

Today, metabolic surgery consists of a 45-minute procedure with 4 or 5 Band-aids and a safety record better than that of appendectomy, hysterectomy or hernia repair.

Similar Recent Posts

  • Bladder & Bowel Leakage Treatment Options – A New Post on Sixty & Me

    • dr-sasse-reno-incontinence-treatment-options

      Dr. Sasse contributes regular articles to Sixty & Me, a wonderful online community of 500,000 women over 60. In his recent post, he included a comprehensive overview of seven treatment options for bladder and bowel leakage. Here’s a short overview of the post, but we encourage you to jump over to Sixty & Me to Read More…

  • Study finds Weight-Loss Surgery Likely Saved Lives of Covid-19 Patients

    • dr-kent-sasse-research-skin-cancer-obesity

      In a recent study from the excellent research team at The Cleveland Clinic, investigators reported the results of obese individuals who acquired COVID-19. They compared two matched groups among a total of 363 COVID-19 patients: one group with obesity and one group with prior morbid obesity but having had weight-loss surgery. The findings were significant. No Read More…

  • Newest Sacral Neuromodulation Device Highly Effective at Two Years

    • dr-kent-sasse-research-skin-cancer-obesity

      The recently released two-year study of 141 patients with urinary incontinence treated with the sacral neuromodulation (SNM) device showed excellent results at the two-year mark. SNM is a twenty-year-old therapy that has been increasingly refined in recent years. The thirty-minute procedure involves placement of a small chip-like device under the skin near a person’s back Read More…

Contact Us with any Questions Regarding your Bariatric Health

It is important that you give us your accurate weight and height, so we can best assist you.

There are Two Ways to Get Started
Actual Patient
Address
Sasse Surgical Associates
75 Pringle Way
Suite 804

Reno, NV 89502
Minimally invasive weight loss surgery experts.info@sassesurgical.com(775) 829-7999
Phone
Office Hours
Monday
7:30 am - 5:00 pm
Tuesday
7:30 am - 5:00 pm
Wednesday
7:30 am - 5:00 pm
Thursday
7:30 am - 5:00 pm
Friday
7:30 am - 3:00 pm
Saturday
Closed
Sunday
Closed